Evidence map›Paper›PMID 36203104›Full record

ReviewPediatric nephrology (Berlin, Germany)2023

The complement system in pediatric acute kidney injury.

Erin K Stenson, Jessica Kendrick, Bradley Dixon, Joshua M Thurman

Open access · bronzeAbstract readReview
In one paragraph

Review in Pediatric nephrology (Berlin, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Preventing pediatric acute kidney injury: is it even possible?Pediatric nephrology (Berlin, Germany) · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Kidney Injury Following Cardiac Surgery: A Review of Our Current Understanding.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2025
    Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Erin K StensonSection of Pediatric Critical Care Medicine, Department of Pediatrics, University of Colorado School of Medicine, 13121 E 17th Avenue, MS8414, Aurora, CO, 80045, USA. Erin.stenson@childrenscolorado.org.
Jessica KendrickDivision of Renal Disease and Hypertension, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
Bradley DixonRenal Section, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA.
Joshua M ThurmanDivision of Renal Disease and Hypertension, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
University of Colorado Denver · US

Funding

Pediatric Critical Care Scientist Development ProgramK12HD047349 · NICHD · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI HEATHER T. KEENAN, Kevin M Watt · 2004 to 2026
$17.0M
The Complement System and Ischemic Acute Renal FailureR01DK076690 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Joshua M Thurman · 2008 to 2026
$6.6M
Evaluating the Association of Dietary Acid Load and Patterns with Cardiovascular Risk and Graft Histology in Kidney Transplant Recipients (KTRs) Across Race/EthnicityR01DK130255 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI KENDRICK, JESSICA B, THURMAN, JOSHUA M · 2021 to 2025
$2.7M
Novel Therapeutic Approaches for Lupus NephritisR01DK125823 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI HOLERS, VERNON MICHAEL, THURMAN, JOSHUA M · 2020 to 2023
$1.8M
NICHD NIH HHS HD047349NICHD NIH HHS K12 HD047349NIDDK NIH HHS R01 DK076690NIDDK NIH HHS R01DK076690NIDDK NIH HHS R01 DK125823NIDDK NIH HHS R01DK125823NIDDK NIH HHS R01 DK130255NIDDK NIH HHS R01DK130255
6 · The paper itself

Abstract

The complement cascade is an important part of the innate immune system. In addition to helping the body to eliminate pathogens, however, complement activation also contributes to the pathogenesis of a wide range of kidney diseases. Recent work has revealed that uncontrolled complement activation is the key driver of several rare kidney diseases in children, including atypical hemolytic uremic syndrome and C3 glomerulopathy. In addition, a growing body of literature has implicated complement in the pathogenesis of more common kidney diseases, including acute kidney injury (AKI). Complement-targeted therapeutics are in use for a variety of diseases, and an increasing number of therapeutic agents are under development. With the implication of complement in the pathogenesis of AKI, complement-targeted therapeutics could be trialed to prevent or treat this condition. In this review, we discuss the evidence that the complement system is activated in pediatric patients with AKI, and we review the role of complement proteins as biomarkers and therapeutic targets in patients with AKI.

Indexed as

Complement System ProteinsKidneyKidney DiseasesAtypical Hemolytic Uremic SyndromeChildComplement ActivationHumansComplement System ProteinsAcute kidney injuryComplementComplement inhibitors

Identifiers

PMID36203104
PMCPMC9540254
OpenAlexW4302362767

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.